Categories Earnings, Markets, Technology

Electronic Arts’ stock is riding high on Apex Legends wave

Electronic Arts Inc. (EA) is still riding the Apex Legends wave, with shares up 4.6% in mid-day trade on Tuesday. The stock has gained since the company reported strong sign-up numbers over the past couple of days.

After its launch on February 4, Apex Legends gained over 10 million sign-ups in just three days and on Monday, Vince Zampella, CEO of Respawn Entertainment, developer of Apex Legends, said that the game had garnered over 25 million players in just a week’s time, with well over 2 million concurrent players at its peak during the weekend.

Although the game is free, these numbers indicate a rapid rise compared to the biggest performer of 2018, Fortnite. It took Fortnite weeks and months to get to the aforementioned numbers following its release.

The stock rallied 11% on Friday and then 6% in after-hours on Monday after the increases in gamer numbers were disclosed. Electronic Arts had suffered a setback on Tuesday after reporting third-quarter 2019 earnings that missed estimates and lowering its full-year 2019 revenue outlook. The stock had crashed over 16% following the results release.

Electronic Arts swings to profit in Q3 but misses estimates

Looking at the past one month, Electronic Arts’ stock has gained 12%. The company’s rival Activision Blizzard (ATVI) is set to report earnings results today after market close.


Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Also Read:  Roku reports a mixed bag of results for Q2

Most Popular

Baidu (BIDU) Q2 earnings rise unexpectedly; stock falls China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the

Applied Materials (AMAT) tops Q3 2020 targets; provides Q4 outlook

Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies